Who Are The Largest Shareholders In FSD Pharma Inc (CNSX:HUGE)?

In this analysis, my focus will be on developing a perspective on FSD Pharma Inc’s (CNSX:HUGE) latest ownership structure, a less discussed, but important factor. Ownership structure has been found to have an impact on shareholder returns in both short- and long-term. Differences in ownership structure of companies can have a profound effect on how management’s incentives are aligned with shareholder returns, and whether they adhere to corporate governance best practices. Although this is an important factor for long-term investors, many investors can also be impacted by institutional presence and their high-volume trading. Now I will analyze HUGE’s shareholder registry in more detail.

Check out our latest analysis for FSD Pharma
CNSX:HUGE Ownership_summary July 6th 18
CNSX:HUGE Ownership_summary July 6th 18

Institutional Ownership

Due to the big order sizes of institutional investors, a company’s shares can experience large, one-sided momentum, driven by high volume of shares removed from, or injected into, the market. With an institutional ownership of 4.83%, HUGE doesn’t seem too exposed to higher volatility resulting from institutional trading.

Insider Ownership

Insiders form a group of important ownership types as they manage the company’s operations and decide the best use of capital. Insider ownership has been linked to better alignment between management and shareholders. A major group of owners of HUGE is individual insiders, sitting with a hefty 17.60% stake in the company. Broadly, insider ownership of this level has been found to negatively affect companies with consistently low PE ratio (underperforming). And a positive impact has been seen on companies with a high PE ratio (outperforming). It’s also interesting to learn what HUGE insiders have been doing with their shareholdings lately. Insiders buying company shares can be a positive indicator of future performance, but a selling decision can simply be driven by personal financial needs.

General Public Ownership

The general public holds a substantial 74.34% stake in HUGE, making it a highly popular stock among retail investors. This size of ownership gives retail investors collective power in deciding on major policy decisions such as executive compensation, appointment of directors and acquisitions of businesses.

Private Company Ownership

Potential investors in HUGE should also look at another important group of investors: private companies, with a stake of 3.23%, who are primarily invested because of strategic and capital gain interests. However, an ownership of this size may be relatively insignificant, meaning that these shareholders may not have the potential to influence HUGE’s business strategy. Thus, investors not need worry too much about the consequences of these holdings.

Next Steps:

Institutional ownership in HUGE is not at a level that would concern investors. We are less likely to see sustained downtrends or significant volatility resulting from large institutional trading. However, ownership structure should not be the only focus of your research when constructing an investment thesis around HUGE. Rather, you should be looking at fundamental drivers such as FSD Pharma’s past track record and financial health. I urge you to complete your research by taking a look at the following:

  1. Financial Health: Is HUGE’s operations financially sustainable? Balance sheets can be hard to analyze, which is why we’ve done it for you. Check out our financial health checks here.
  2. Other High-Performing Stocks: Are there other stocks that provide better prospects with proven track records? Explore our free list of these great stocks here.
NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures.